Although Dahmani et al. reported that systemic levels of 11-oxyandrogens decline after tumor removal, suggesting tumor-driven regulation [34], our recent findings show that CYP11B1 is not expressed in EC tumors or in vitro cell lines [35]. Here, CYP11B1 is linked to neoplasm.